EP268: COVID-19—After June: Action Steps for Hospitals, Payers, Employers, and Pharma, With Marty Makary, MD, MPH
April 02, 2020
268
27:14

EP268: COVID-19—After June: Action Steps for Hospitals, Payers, Employers, and Pharma, With Marty Makary, MD, MPH

The reaction of some hospitals and health care systems to the COVID-19 pandemic has been truly breathtaking. Doctors, nurses, first responders, other staff at hospitals and elsewhere have worked hard—so hard—to support the national effort. The same can be said to some tech entrepreneurs and other businesses who have snapped into action in order to provide PPE (personal protective equipment) and artificial intelligence to the frontline health care workers.

In this health care podcast, I’m talking again with Marty Makary, MD, MPH. Dr. Makary is a surgeon at Johns Hopkins, professor of surgery and health policy and management at Johns Hopkins University, and the author of The Price We Pay and Unaccountable. So, this is episode 268. In this particular episode, Dr. Makary and I discuss the situation that will likely play out after the “reactive” phase of this COVID-19 pandemic (ie, March, April, May). 

After about June, the pandemic, according to Dr. Makary, will start to wind down a bit; and at that juncture, there’s going to be a backlog of patients who had their elective surgeries postponed and their care journeys potentially interrupted if they required an in-person visit or a lab test or an imaging study that did not happen. There will be a need to prioritize them, something that we have never really done in this country before. This is what we’re going to talk about in this episode: this second phase.

Potential point of interest: Episode 267 (the one right before this episode) is about the here and now, prior to the peak, if you want to go back and listen to that when you have time. 

You can learn more at martymd.com or connect with Dr. Makary on Twitter at @MartyMakary. 

Martin “Marty” Makary, MD, MPH, is an American surgeon, New York Times best-selling author, and Johns Hopkins health policy expert. He has written for The Wall Street Journal, USA Today, Time, Newsweek, and CNN and appears on NBC and Fox News. He has written extensively on organizational culture, the science of measuring quality in medicine, and health care reform. Dr. Makary is the author of two best-selling books: Mama Maggie, a book about a Nobel Prize nominee, and Unaccountable, a book about health care transparency. He also recently released The Price We Pay: What Broke American Health Care—and How to Fix It. This book offers a road map for everyday Americans and business leaders to get a better deal on their health care and profiles the disruptors who are innovating medical care.

Dr. Makary is principal investigator of a Robert Wood Foundation grant to lower health care costs in the United States by creating physician-endorsed measures of appropriate medical care and directs the national “Improving Wisely” project to reduce waste in medicine. He speaks nationally on disruptive innovation in health care. Dr. Makary is a frequent medical commentator of NBC and Fox News, commenting on the health care cost crisis, the impact of new technology, and interpreting the latest medical research for everyday consumers. Dr. Makary is director of the Center for Opioid Research and Education and founder of solvethecrisis.org, a Web site that shares expert opioid prescribing recommendations for common medical procedures for clinicians and patients. 

At Johns Hopkins, he has served as the endowed chair of gastrointestinal surgery, director of surgical quality and safety, and founding director of the Johns Hopkins Center for Surgical Outcomes Research and Clinical Trials. Dr. Makary is a surgical oncologist specializing in minimally invasive surgery and teaches health policy and management at the Johns Hopkins University School of Medicine. He currently serves as the chief of the Johns Hopkins Center for Islet Transplantation and director of the appropriateness in medicine project.


02:23 What “normal” will look like in June.
03:46 Why people who need basic medical care right now aren’t getting that care.
06:13 “For the first time, we’ve got to think now about prioritizing which patients need to get in line first.”
07:51 “We see gaming of the system.”
08:05 “We don’t do a good job of prioritizing.”
10:07 Why teamwork and team building are a problem in medicine.
12:57 The incredible heritage of the medical profession.
13:52 Will there be a decrease in outcomes?
14:33 Why lowering insurance deductibles will be key in making successful strides on the other side of this pandemic.
17:23 The great things to come out of the pandemic.
21:41 “Everybody’s right … [they’re just] looking at it from their point of view.”
21:56 What’s in store for pharmacies coming out of this pandemic.
24:53 What hospital executives should be doing, looking and planning months out from now.
25:48 “We’ve never asked ourselves, ‘What would take priority?’”

COVID19,Covid,coronavirus,digitalhealth,healthcare,healthtech,pandemic,johns hopkins,

Recent Episodes

Take Two: EP438: Is It Mission and/or Margin? With John Lee, MD
July 03, 202535:5932.93 MB

Take Two: EP438: Is It Mission and/or Margin? With John Lee, MD

Listen On Your Favorite App I am so focused right now on the intersection (or lack thereof) of mission and margin, so I’m taking a second listen to this episode right now with John Lee, MD, because it is so ridiculously relevant given that I am, as stated, on a bit of a tear. For a full transcript ...

EP480: Payment Integrity Meets Health System Boasts, Such as Our Rates Are 2x Medicare, With Kimberly Carleson
June 26, 2025
480
32:0629.38 MB

EP480: Payment Integrity Meets Health System Boasts, Such as Our Rates Are 2x Medicare, With Kimberly Carleson

Listen On Your Favorite App You know that episode from this spring with Eric Bricker, MD ( EP472 ) about stop-loss provisions as a way for some hospitals so inclined to make more money without (technically, at least) raising rates—like, they can substantially increase the overall revenue from plan ...

Pharma Rebates: A Few Nuances You May Not Have Thought Of, With Ann Lewandowski—Summer Shorts
June 19, 202519:2717.81 MB

Pharma Rebates: A Few Nuances You May Not Have Thought Of, With Ann Lewandowski—Summer Shorts

Listen On Your Favorite App So much can be said about pharma rebates or, as I’m starting to call them after speaking with my guest today, Ann Lewandowski, monies received back from manufacturers or even post-sale concessions. And we get a little bit into this today why rebates is just so much lingu...

EP479: What Could Go Wrong Covering High-Cost Claimants With Stop-Loss Reinsurance? With Andreas Mang and Jon Camire
June 12, 2025
479
27:2525.09 MB

EP479: What Could Go Wrong Covering High-Cost Claimants With Stop-Loss Reinsurance? With Andreas Mang and Jon Camire

Listen On Your Favorite App This show today, for sure, it’s for plan sponsors and anyone on or about plan sponsors; but also listen if you are serving high-cost claimants some other way. Because what you’ll learn here today is some insights relative to how plan sponsors go about making sure that th...

Take Two: EP433: The Mystery of the Weekly Claims Wire, With Justin Leader
June 05, 202538:4935.53 MB

Take Two: EP433: The Mystery of the Weekly Claims Wire, With Justin Leader

Listen On Your favorite App I decided to take a second listen to this episode due to the large number of posts on LinkedIn and conversations by the likes of Peter Hayes , Jamie Greenleaf , Steve Ditto , Julie Selesnick , Chris Deacon , Darren Fogarty just about the dollars disappearing when TPAs (t...

EP478: Stop-Loss Coverage, Part 1: How It Goes Right, and How It Can Go Horribly Wrong, With Andreas Mang and Jon Camire
May 29, 2025
478
31:5829.26 MB

EP478: Stop-Loss Coverage, Part 1: How It Goes Right, and How It Can Go Horribly Wrong, With Andreas Mang and Jon Camire

Listen On Your Favorite App Hey, question for you. Can it ever actually be better for a claim to get lasered? If your knee-jerk reaction is, “Nope. No, not so much. Lasered claims are always bad,” and/or if you have no idea what I’m talking about, do continue to listen. This question gets answered....

EP477: Through Line Show: What the Tribe Thinks You Need to Know About Trust or It’s Gonna Be a Problem. Also, Why You Are Smart, With Stacey Richter
May 22, 2025
477
18:3325.47 MB

EP477: Through Line Show: What the Tribe Thinks You Need to Know About Trust or It’s Gonna Be a Problem. Also, Why You Are Smart, With Stacey Richter

Listen On Your Favorite App A couple months ago, I did my very first episode ( EP467 ) that locked down a very clear through line, a theme tying together a bunch of RHV (Relentless Health Value) episodes from earlier this year. That earlier through line was a lack of good primary care means higher ...

Listen and Follow

Sponsored by Aventria Health Group
©2025 BD Bridges LLC. All Rights Reserved.